SMTL ID : 1vbd.2 (3 other biounits)

POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-5-5-5-5-mer

Ligands

5 x GLY- SER- SER- SER- THR: POLIOVIRUS TYPE 1 MAHONEY(Non-covalent)

GLY-SER-SER-SER-THR.1: 5 residues within 4Å: Chain D: G.1, A.2, Q.3, V.4 Ligands: MYR.15 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:Q.3, D:Q.3, D:V.4 GLY-SER-SER-SER-THR.4: 5 residues within 4Å: Chain H: G.1, A.2, Q.3, V.4 Ligands: MYR.3 3 PLIP interactions: 3 interactions with chain H Hydrogen bonds: H:Q.3, H:Q.3, H:V.4 GLY-SER-SER-SER-THR.7: 5 residues within 4Å: Chain L: G.1, A.2, Q.3, V.4 Ligands: MYR.6 3 PLIP interactions: 3 interactions with chain L Hydrogen bonds: L:Q.3, L:Q.3, L:V.4 GLY-SER-SER-SER-THR.10: 5 residues within 4Å: Chain P: G.1, A.2, Q.3, V.4 Ligands: MYR.9 3 PLIP interactions: 3 interactions with chain P Hydrogen bonds: P:Q.3, P:Q.3, P:V.4 GLY-SER-SER-SER-THR.13: 5 residues within 4Å: Chain T: G.1, A.2, Q.3, V.4 Ligands: MYR.12 3 PLIP interactions: 3 interactions with chain T Hydrogen bonds: T:Q.3, T:Q.3, T:V.4

5 x J78: (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE(Non-covalent)

J78.2: 17 residues within 4Å: Chain A: I.110, T.111, Y.112, M.132, L.134, I.157, Y.159, P.181, S.182, I.183, I.194, V.196, V.199, Y.205, F.237, L.240 Chain C: A.24 13 PLIP interactions: 12 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: A:I.110, A:Y.112, A:Y.159, A:Y.159, A:Y.159, A:P.181, A:I.183, A:I.194, A:V.199, A:F.237, C:A.24 pi-Stacking: A:Y.205, A:F.237 J78.5: 17 residues within 4Å: Chain E: I.110, T.111, Y.112, M.132, L.134, I.157, Y.159, P.181, S.182, I.183, I.194, V.196, V.199, Y.205, F.237, L.240 Chain G: A.24 13 PLIP interactions: 1 interactions with chain G, 12 interactions with chain E Hydrophobic interactions: G:A.24, E:I.110, E:Y.112, E:Y.159, E:Y.159, E:Y.159, E:P.181, E:I.183, E:I.194, E:V.199, E:F.237 pi-Stacking: E:Y.205, E:F.237 J78.8: 17 residues within 4Å: Chain I: I.110, T.111, Y.112, M.132, L.134, I.157, Y.159, P.181, S.182, I.183, I.194, V.196, V.199, Y.205, F.237, L.240 Chain K: A.24 13 PLIP interactions: 12 interactions with chain I, 1 interactions with chain K Hydrophobic interactions: I:I.110, I:Y.112, I:Y.159, I:Y.159, I:Y.159, I:P.181, I:I.183, I:I.194, I:V.199, I:F.237, K:A.24 pi-Stacking: I:Y.205, I:F.237 J78.11: 17 residues within 4Å: Chain M: I.110, T.111, Y.112, M.132, L.134, I.157, Y.159, P.181, S.182, I.183, I.194, V.196, V.199, Y.205, F.237, L.240 Chain O: A.24 13 PLIP interactions: 12 interactions with chain M, 1 interactions with chain O Hydrophobic interactions: M:I.110, M:Y.112, M:Y.159, M:Y.159, M:Y.159, M:P.181, M:I.183, M:I.194, M:V.199, M:F.237, O:A.24 pi-Stacking: M:Y.205, M:F.237 J78.14: 17 residues within 4Å: Chain Q: I.110, T.111, Y.112, M.132, L.134, I.157, Y.159, P.181, S.182, I.183, I.194, V.196, V.199, Y.205, F.237, L.240 Chain S: A.24 13 PLIP interactions: 1 interactions with chain S, 12 interactions with chain Q Hydrophobic interactions: S:A.24, Q:I.110, Q:Y.112, Q:Y.159, Q:Y.159, Q:Y.159, Q:P.181, Q:I.183, Q:I.194, Q:V.199, Q:F.237 pi-Stacking: Q:Y.205, Q:F.237

5 x MYR: MYRISTIC ACID(Covalent)

MYR.3: 10 residues within 4Å: Chain D: G.1, A.2, I.29, Y.31 Chain H: V.4, T.27, T.28, I.29, Y.31 Ligands: GLY-SER-SER-SER-THR.4 4 PLIP interactions: 2 interactions with chain H, 2 interactions with chain D Hydrophobic interactions: H:I.29, D:I.29, D:Y.31 Hydrogen bonds: H:T.27 MYR.6: 10 residues within 4Å: Chain H: G.1, A.2, I.29, Y.31 Chain L: V.4, T.27, T.28, I.29, Y.31 Ligands: GLY-SER-SER-SER-THR.7 3 PLIP interactions: 2 interactions with chain H, 1 interactions with chain L Hydrophobic interactions: H:I.29, H:Y.31, L:I.29 MYR.9: 10 residues within 4Å: Chain L: G.1, A.2, I.29, Y.31 Chain P: V.4, T.27, T.28, I.29, Y.31 Ligands: GLY-SER-SER-SER-THR.10 3 PLIP interactions: 1 interactions with chain P, 2 interactions with chain L Hydrophobic interactions: P:I.29, L:I.29, L:Y.31 MYR.12: 10 residues within 4Å: Chain P: G.1, A.2, I.29, Y.31 Chain T: V.4, T.27, T.28, I.29, Y.31 Ligands: GLY-SER-SER-SER-THR.13 4 PLIP interactions: 2 interactions with chain P, 2 interactions with chain T Hydrophobic interactions: P:I.29, P:Y.31, T:I.29 Hydrogen bonds: T:T.27 MYR.15: 10 residues within 4Å: Chain D: V.4, T.27, T.28, I.29, Y.31 Chain T: G.1, A.2, I.29, Y.31 Ligands: GLY-SER-SER-SER-THR.1 4 PLIP interactions: 2 interactions with chain D, 2 interactions with chain T Hydrophobic interactions: D:I.29, T:I.29, T:Y.31 Hydrogen bonds: D:T.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)

Release Date

1996-07-11

Peptides

POLIOVIRUS TYPE 1 MAHONEY: AEIMQ
POLIOVIRUS TYPE 1 MAHONEY: BFJNR
POLIOVIRUS TYPE 1 MAHONEY: CGKOS
POLIOVIRUS TYPE 1 MAHONEY: DHLPT

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

B
2

F
2

J
2

N
2

R
2

C
3

G
3

K
3

O
3

S
3

D
4

H
4

L
4

P
4

T
4

POLIOVIRUS TYPE 1 MAHONEY

POLIOVIRUS TYPE 1 MAHONEY

POLIOVIRUS TYPE 1 MAHONEY

POLIOVIRUS TYPE 1 MAHONEY

Related Entries With Identical Sequence